TIME-RELATED INCREASE IN HEMATOCRIT ON CHRONIC-HEMODIALYSIS - UNCERTAIN ROLE OF RENAL CYSTS

被引:14
作者
GLICKLICH, D
KUTCHER, R
ROSENBLATT, R
BARTH, RH
机构
[1] MONTEFIORE MED CTR,DEPT RADIOL,BRONX,NY 10467
[2] YESHIVA UNIV ALBERT EINSTEIN COLL MED,BRONX,NY 10461
[3] VET ADM MED CTR,DEPT MED,DIV RENAL,BROOKLYN,NY 11209
关键词
acquired cystic disease; Anemia; hemodialysis;
D O I
10.1016/S0272-6386(12)80591-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We studied the long-term changes in hematocrit in 283 center hemodialysis patients. Mean duration of dialysis (± SD) was 53.8 ± 43.4 months, with a range of 6 to 176 months. The correlations of hematocrit with clinical factors, laboratory values, and renal cystic changes were investigated. Time on dialysis was the strongest single predictor of hematocrit for the whole group (r = 0.351, P < 0.001) and for men and women analyzed separately. Longitudinal 5-year (n = 83) and 10-year (n = 21) data showed a continuous increase in hematocrit levels over time (r = 0.414, P < 0.001 over 10 years). Patients at the dialyzer reuse center (n = 224) had higher hematocrit levels than those at the center that did not reuse (n = 59). Although time on dialysis was strongly correlated with increasing extent of renal cystic change (r = 0.387, P < 0.001), the correlations of cyst extent and time on dialysis with hematocrit were not independent by multiple regression analysis. We conclude that hematocrit increases progressively over time in patients on chronic hemodialysis. The mechanisms responsible for this do not seem to involve cystic transformation of the kidneys and remain unclear. © 1990, National Kidney Foundation, Inc.. All rights reserved.
引用
收藏
页码:46 / 54
页数:9
相关论文
共 30 条
[1]  
ANAGNOSTOU A, 1985, SEMIN NEPHROL, V5, P115
[2]  
ANAGNOSTOU A, 1985, SEMIN NEPHROL, V5, P104
[3]   SPONTANEOUS INCREASE IN ERYTHROPOIETIN AND HEMATOCRIT VALUE ASSOCIATED WITH TRANSIENT LIVER-ENZYME ABNORMALITIES IN AN ANEPHRIC PATIENT UNDERGOING HEMODIALYSIS [J].
BROWN, S ;
CARO, J ;
ERSLEV, AJ ;
MURRAY, TG .
AMERICAN JOURNAL OF MEDICINE, 1980, 68 (02) :280-284
[4]   ACUTE HEPATITIS AND ERYTHROPOIESIS IN CHRONICALLY HEMODIALYZED PATIENTS [J].
BRUNOIS, JP ;
LAVAUD, S ;
MELIN, JP ;
DIEBOLD, M ;
TOUPANCE, O ;
CHANARD, J .
NEPHRON, 1981, 28 (03) :152-153
[5]  
CARO J, 1985, SEMIN NEPHROL, V5, P128
[6]   SERUM IMMUNOREACTIVE ERYTHROPOIETIN LEVELS IN PATIENTS WITH POLYCYSTIC KIDNEY-DISEASE AS COMPARED WITH OTHER HEMODIALYSIS-PATIENTS [J].
CHANDRA, M ;
MILLER, ME ;
GARCIA, JF ;
MOSSEY, RT ;
MCVICAR, M .
NEPHRON, 1985, 39 (01) :26-29
[7]   ABSENCE OF ANEMIA IN MAINTENANCE HEMODIALYSIS [J].
CHARLES, G ;
LUNDIN, AP ;
DELANO, BG ;
BROWN, C ;
FRIEDMAN, EA .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1981, 4 (06) :277-279
[8]  
COLEMAN J C, 1972, British Journal of Urology, V44, P194, DOI 10.1111/j.1464-410X.1972.tb10065.x
[9]   CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL [J].
ESCHBACH, JW ;
EGRIE, JC ;
DOWNING, MR ;
BROWNE, JK ;
ADAMSON, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) :73-78
[10]   IMPROVEMENT IN ANEMIA OF CHRONIC RENAL-FAILURE WITH FLUOXYMESTERONE [J].
ESCHBACH, JW ;
ADAMSON, JW .
ANNALS OF INTERNAL MEDICINE, 1973, 78 (04) :527-532